Updates and controversies for desmoids in familial adenomatous polyposis
Familial Cancer · 2025
DOI: 10.1007/s10689-025-00481-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Familial Cancer, 2025. Verfasst von Rami James N Aoun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, 410 W …. Hauptthemen laut MEDLINE: Adenomatous Polyposis Coli, Desmoid Tumors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Desmoids are rare non-cancerous fibrous growths with variable behavior ranging from slow indolent growth or even regression, to locally aggressive and progressive tumors that can cause significant morbidity or mortality. Approximately 10–15% of patients with familial adenomatous polyposis (FAP) develop desmoid disease, most commonly located in the abdomen, on the abdominal wall, or in limbs. The majority of desmoids in FAP occur after abdominal surgery. Management is quite challenging and employing a multidisciplinary team at a specialized center is important for success. New treatment modalities have emerged, including tyrosine kinase inhibitors, γ-secretase inhibitors, and ablation techniques, complementing the existing repertoire of therapies such as NSAIDs, anti-hormonal therapy, chemotherapy, radiotherapy, and surgical interventions. Surgery remains the treatment of choice for easily resectable abdominal wall desmoids and intra-abdominal desmoids that cause intractable symptoms, or progressive disease despite alternate therapies, or complications from the invasion of nearby organs. When considering prophylactic colectomies in FAP patients, it’s essential to account for the desmoidogenic potential of surgical interventions, especially in high-risk individuals with a positive family history of desmoids, presence of extracolonic manifestations and carriers of certain genotypes. Given the rarity of the disease and the variability in both anatomical presentation and clinical course, desmoids should be managed by a multidisciplinary team capable of coordinating patient specific care and optimizing treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Colorectal Surgery, Department of Surgery, The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, 410 W 10th Ave, Doan Hall 737B, Columbus, OH, 43210, USA.
- Division of Colorectal Surgery, Department of Surgery, The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, 410 W 10th Ave, Doan Hall 737B, Columbus, OH, 43210, USA. matthew.kalady@osu…
Zitieren
APA
Aoun, R. J. N., & Kalady, M. F. (2025). Updates and controversies for desmoids in familial adenomatous polyposis. Familial Cancer. https://doi.org/10.1007/s10689-025-00481-9
Vancouver
Aoun RJN, Kalady MF. Updates and controversies for desmoids in familial adenomatous polyposis. Familial Cancer. 2025. doi:10.1007/s10689-025-00481-9
BibTeX
@article{Aoun2025,
author = {Aoun, Rami James N and Kalady, Matthew F},
title = {Updates and controversies for desmoids in familial adenomatous polyposis},
journal = {Familial Cancer},
year = {2025},
doi = {10.1007/s10689-025-00481-9}
}
EUVIMED